DOX
Amdocs Limited
DOX trails on the overall score without a compensating advantage in the available component scores.
MU
Micron Technology, Inc.
MU has the edge over DOX overall, supported by stronger modeled upside and stronger fundamentals.
DOX Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Healthy |
DOX's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
MU Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
MU's revenue, profitability, cash flow and balance sheet are all currently strong.
DOX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 8.1x | $44.11 | — |
| Current | 11x | $44.11 | — |
| Cheap | 14x | $60.81 | +38% |
| Fair | 18x | $76.51 | +73% |
| Expensive | 20x | $85.23 | +93% |
Historical ranges are pointers, not guarantees.
DOX has the edge over MU in the historical PE scenario, which offers more potential upside but is not a forecast.
MU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.6x | $798 | — |
| Cheap | 10x | $777 | -2.7% |
| Current | 11x | $798 | — |
| Fair | 22x | $1,646 | +106% |
| Expensive | 32x | $2,404 | +201% |
Historical ranges are pointers, not guarantees.
MU's PE is in its cheap range at 11x. If earnings grow as analysts expect, today's price would be 4.6x next year's earnings.
DOX Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong decline | |
| Decline | |
| Weakening | |
| Limited | |
| Low |
Analysts expect DOX's earnings and revenue to decline, with profitability weakening. However, they disagree widely on these estimates.
MU Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Moderate |
MU has the edge over DOX on the outlook, with more favorable earnings and revenue expectations.
DOX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.47 | +30% |
| Q2 2026 | $4.20 | -14% |
| Q1 2026 | $5.00 | +5.9% |
| Q4 2025 | $5.17 | +21% |
| Q3 2025 | $5.05 | +20% |
| Q2 2025 | $4.90 | +13% |
| Q1 2025 | $4.72 | +6.1% |
| Q4 2024 | $4.28 | -8.4% |
| Q3 2024 | $4.21 | -6% |
DOX earned $4.20 per share over the past year, down 14% from the year before.
MU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $174.95 | +135% |
| Q3 2026 | $74.33 | +879% |
| Q2 2026 | $44.17 | +693% |
| Q1 2026 | $21.18 | +405% |
| Q4 2025 | $10.52 | +201% |
| Q3 2025 | $7.59 | +984% |
| Q2 2025 | $5.57 | +$6.99 |
| Q1 2025 | $4.19 | +$7.64 |
| Q4 2024 | $3.49 | +$9.77 |
MU has the edge over DOX on earnings, with more consistent year-over-year improvement.
DOX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1.2B | +2.7% |
| Q1 2026 | $1.2B | +3.9% |
| Q4 2025 | $1.2B | +4.1% |
| Q3 2025 | $1.2B | -9% |
| Q2 2025 | $1.1B | -8.4% |
| Q1 2025 | $1.1B | -9.4% |
| Q4 2024 | $1.1B | -11% |
| Q3 2024 | $1.3B | +1.7% |
DOX's revenue grew through 2021 and has held roughly level since: $1.2B last quarter, up 2.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 18% | +0.3 points |
| Q1 2026 | 16% | -1.1 points |
| Q4 2025 | 18% | 0 points |
| Q3 2025 | 18% | +9 points |
| Q2 2025 | 18% | +3.6 points |
| Q1 2025 | 18% | +5 points |
| Q4 2024 | 18% | +3.1 points |
| Q3 2024 | 8.9% | -2.3 points |
DOX's operating margin was 18% last quarter, about level with the same quarter a year ago, near the top of its range since 2019.
MU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.2B | +379% |
| Q2 2026 | $41.5B | +346% |
| Q1 2026 | $23.9B | +196% |
| Q4 2025 | $13.6B | +57% |
| Q3 2025 | $11.3B | +46% |
| Q2 2025 | $9.3B | +37% |
| Q1 2025 | $8.1B | +38% |
| Q4 2024 | $8.7B | +84% |
MU has the edge over DOX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 81% | +48 points |
| Q2 2026 | 80% | +57 points |
| Q1 2026 | 68% | +46 points |
| Q4 2025 | 45% | +20 points |
| Q3 2025 | 32% | +13 points |
| Q2 2025 | 23% | +13 points |
| Q1 2025 | 22% | +19 points |
| Q4 2024 | 25% | +49 points |
MU has the edge over DOX on profitability, with a higher operating margin.
DOX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $171.9M | -19% |
| Q1 2026 | $80.3M | -49% |
| Q4 2025 | $187.9M | +140% |
| Q3 2025 | $198.6M | +3.4% |
| Q2 2025 | $211.8M | +21% |
| Q1 2025 | $156.5M | +38% |
| Q4 2024 | $78.2M | -44% |
| Q3 2024 | $192.1M | -22% |
DOX's free cash flow has been positive every quarter for seven years: $639M over the past year, about the same as the year before.
MU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.9B | +45543% |
| Q2 2026 | $17.6B | +951% |
| Q1 2026 | $5.5B | +$5.6B |
| Q4 2025 | $3B | +7853% |
| Q3 2025 | $72M | -75% |
| Q2 2025 | $1.7B | +322% |
| Q1 2025 | -$113M | +$52M |
| Q4 2024 | $38M | +$433M |
MU has the edge over DOX on cash flow, with more consistent year-over-year improvement.
DOX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.7% | -1.8M shares |
| 1 year | -4.9% | -5.5M shares |
| 3 years | -12% | -14.7M shares |
| 5 years | -17% | -22.4M shares |
| Available history | -22% | -30.5M shares |
DOX has the edge over MU on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $142.6M |
| Q1 2026 | $138.3M |
| Q4 2025 | $146.2M |
| Q3 2025 | $136.4M |
| Q2 2025 | $135.2M |
| Q1 2025 | $135.2M |
| Q4 2024 | $144.5M |
| Q3 2024 | $119.8M |
DOX spent $563M buying back its own shares over the past year, up 5.4% from the year before.
MU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -2M shares |
| 1 year | +1.6% | +18M shares |
| 3 years | +4.6% | +50M shares |
| 5 years | +0.2% | +2M shares |
| Available history | +1.2% | +14M shares |
MU has 1.1B diluted shares, up 1.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $350M |
| Q4 2025 | $300M |
| Q3 2024 | $300M |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
MU has spent almost nothing on buybacks in the past year.
DOX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 1.0x | Healthy |
| Q1 2026 | 0.9x | Very low |
| Q4 2025 | 0.7x | Very low |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.7x | Very low |
| Q4 2024 | 0.7x | Very low |
| Q3 2024 | 0.6x | Very low |
DOX's net debt is about a year of its operating earnings (EBITDA), up from less than a year a year ago.
MU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
MU has the edge over DOX on leverage, with a lower net debt burden relative to earnings.
DOX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.4 | Neutral |
| Stochastic | 36.7 | Neutral |
DOX's weekly RSI is 30 (neutral) and its Stochastic is 37 (neutral).
MU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 26.9 | Neutral |
MU's weekly RSI is 47 (neutral) and its Stochastic is 27 (neutral).
DOX PE vs Technology Sector
| Metric | DOX | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 62% below |
| PE % | 2 | 35 | 33 pts below |
DOX has the edge over MU on valuation relative to its sector.
MU PE vs Technology Sector
| Metric | MU | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 18 | 35 | 17 pts below |
MU is trading at 11x earnings, a 61% discount to the Technology sector's median of 28x.
DOX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $55.8 | 21% below |
| 20 week MA | $56.7 | 22% below |
| 50 week MA | $64.2 | 31% below |
| 100 week MA | $75.3 | 41% below |
| 200 week MA | $81.7 | 46% below |
DOX is in a downtrend: it's below all five of its weekly moving averages, and 46% below its 200-week average.
MU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $914.5 | 13% below |
| 20 week MA | $931.0 | 14% below |
| 50 week MA | $685.9 | 16% above |
| 100 week MA | $405.4 | 97% above |
| 200 week MA | $246.0 | 225% above |
MU has the edge over DOX on trend strength, trading above more of its moving averages.
DOX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $72.6 | $69.7 | -4.1% |
| 2021 | $69.7 | $74.3 | +6.7% |
| 2022 | $74.3 | $89.4 | +20% |
| 2023 | $89.4 | $87.9 | -1.6% |
| 2024 | $87.9 | $85.8 | -2.4% |
| 2025 | $85.8 | $81.7 | -4.7% |
| 2026 YTD | $81.7 | $44.1 | -46% |
DOX has finished three years in a row lower, and it's down 46% so far in 2026.
MU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.0 | $70.6 | +31% |
| 2021 | $70.6 | $94.4 | +34% |
| 2022 | $94.4 | $50.2 | -47% |
| 2023 | $50.2 | $85.3 | +70% |
| 2024 | $85.3 | $88.6 | +3.9% |
| 2025 | $88.6 | $284.8 | +221% |
| 2026 YTD | $284.8 | $798.4 | +180% |
MU has the edge over DOX on returns for 2026, with the stronger performance.